Integral Health Asset Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001773206

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 94 positions · Total reported value $1.54B · Top-10 concentration 41.9% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.2% · 35 new · 28 cut · 31 exited

Active Share (vs S&P 500): 97.5% · vs QQQ: 98.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -11.2% · vs SPY -13.3% · Prev Value $2.22B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.3% · vs SPY -2.5% · Latest Value $1.54B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Integral Health Asset Management, LLC disclosed 94 equity positions with a combined reported value of $1.54B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were RVMD ($130.34M), INSM ($128.98M), CYTK ($72.50M). By sector, the heaviest allocations are Health Care 96.1%, Industrials 1.7%. Versus the prior quarter, allocation shifted toward Health Care (+3.1pp), Industrials (+0.7pp) and away from Consumer Staples (-3.7pp).

Versus the prior quarter, Integral Health Asset Management, LLC opened 35 new positions, trimmed 28 and fully exited 31, a turnover rate of 75.2% of positions. The portfolio's overlap with the prior quarter was 47% of names.

The largest new positions opened in Q3 2026 were AMGN ($31.61M), INCY ($19.42M), ONC ($18.30M).

Of the 31 positions fully exited versus the prior quarter, the largest were ALHC ($47.62M), ABT ($36.30M), UNH ($35.33M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • AMGN AMGEN INC · $31.61M
  • INCY INCYTE CORP · $19.42M
  • ONC BEONE MEDICINES LTD · $18.30M
  • BDX BECTON DICKINSON & CO · $17.90M
  • EHC ENCOMPASS HEALTH CORP · $14.58M
  • BMY BRISTOL-MYERS SQUIBB CO · $12.48M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · $11.88M
  • SRZN SURROZEN INC · $10.46M

Fully Exited (vs previous quarter)

  • ALHC ALIGNMENT HEALTHCARE INC · prev qtr: $47.62M
  • ABT ABBOTT LABORATORIES · prev qtr: $36.30M
  • UNH UNITEDHEALTH GROUP INC · prev qtr: $35.33M
  • LNTH LANTHEUS HLDGS INC · prev qtr: $21.08M
  • ELV ELEVANCE HEALTH INC FORMERLY · prev qtr: $19.34M
  • LLY ELI LILLY & CO · prev qtr: $17.99M
  • ARWR ARROWHEAD PHARMACEUTICALS IN · prev qtr: $16.30M
  • NVST ENVISTA HOLDINGS CORPORATION · prev qtr: $15.81M

Insider Transactions (Form 4)

Latest Integral Health Asset Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Integral Health Asset Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 94 positions worth $1.54B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-119048 (status: Approved), registered 2020-07-14
  • Regulatory AUM (Form ADV): $1.87B as of 2026-03-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: integralhlth.com

Portfolio Structure

  • 94 positions · $1.54B reported value (Q3 2026)
  • Top 10 holdings = 41.9% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 8.4%
  • Average position size: $16.41M

Sector Tilt

  • Health Care 96.1%
  • Industrials 1.7%
  • Consumer Staples 1.4%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q3 2026: 35 new, 12 added, 28 reduced, 31 exited
  • 19 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is actively increasing exposure to high-growth biotech/healthcare names (RVMD, SRRK, CNC) and large-cap healthcare (MRK, AMGN), while reducing positions in smaller/mid-cap biotechs (AXSM, VERA, LFST), suggesting a tactical tilt toward larger, more established players with potential upside. 2. Key moves: - Added: RVMD (shares +233.3%), MRK (+28.6%), SRRK (+67.3%), CNC (+150.0%). - Reduced: AXSM (-16.7%), VERA (-14.3%), LFST (-13.3%). - New: AMGN (initial position). - Held: INSM, CYTK. 3. Portfolio structure: Active, concentrated (94 positions), heavily biased toward Health Care (100% of top 10). Moderate risk appetite—mix of high-growth biotech (RVMD, SRRK) and stable large-caps (MRK, AMGN). 4. Per-holding one-liner: - RVMD: Biotech developing cancer therapies (unverified). - INSM: Biotech focused on rare diseases (unverified). - CYTK: Biotech targeting muscular/heart diseases (unverified). - MRK: Large-cap pharmaceutical (Merck). - SRRK: Biotech developing muscle-targeted therapies (unverified). - CNC: Managed healthcare provider (Centene). - AXSM: Biotech pain therapeutics (unverified). - VERA: Biotech kidney/immunology drugs (unverified). - AMGN: Large-cap biotech (Amgen). - LFST: Mental healthcare provider (Lifestance). 5. Style summary: The fund tactically shifted toward larger, more established healthcare names while selectively boosting high-growth biotech positions, reducing exposure to smaller/mid-cap biotechs.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:31

Sector Allocation

Health Care 96.1%
Other 0.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.00M $130.34M 8.45%
8.45%
Add
2 1.60M $128.98M 8.36%
8.36%
Hold
3 1.60M $72.50M 4.70%
4.70%
Hold
4 450.00K $65.39M 4.24%
4.24%
Add
5 1.25M $60.64M 3.93%
3.93%
Add
6 750.00K $46.59M 3.02%
3.02%
Add
7 250.00K $46.10M 2.99%
2.99%
Reduce
8 1.50M $32.29M 2.09%
2.09%
Reduce
9 75.00K $31.61M 2.05%
2.05%
New
10 2.60M $31.28M 2.03%
2.03%
Reduce
11 40.00K $30.33M 1.97%
1.97%
Hold
12 90.00K $23.00M 1.49%
1.49%
Reduce
13 100.00K $22.59M 1.46%
1.46%
Hold
14 1.00M $22.45M 1.46%
1.46%
Hold
15 100.00K $22.25M 1.44%
1.44%
Reduce
16 500.00K $21.42M 1.39%
1.39%
Reduce
17 150.00K $21.28M 1.38%
1.38%
Hold
18 40.00K $20.91M 1.35%
1.35%
Hold
19 1.70M $20.20M 1.31%
1.31%
Reduce
20 300.00K $19.74M 1.28%
1.28%
Add
21 160.00K $19.42M 1.26%
1.26%
New
22 500.00K $19.03M 1.23%
1.23%
Reduce
23 325.00K $18.44M 1.20%
1.20%
Reduce
24 50.00K $18.30M 1.19%
1.19%
New
25 2.00M $18.29M 1.19%
1.19%
Hold
26 470.00K $18.04M 1.17%
1.17%
Add
27 100.00K $17.90M 1.16%
1.16%
New
28 400.00K $17.46M 1.13%
1.13%
Reduce
29 200.00K $17.26M 1.12%
1.12%
Reduce
30 1.13M $16.57M 1.07%
1.07%
Add
31 375.00K $15.20M 0.98%
0.98%
Add
32 175.00K $15.10M 0.98%
0.98%
Reduce
33 90.00K $14.78M 0.96%
0.96%
Reduce
34 120.00K $14.58M 0.94%
0.94%
New
35 100.00K $14.26M 0.92%
0.92%
Reduce
36 1.30M $14.00M 0.91%
0.91%
Add
37 55.00K $12.82M 0.83%
0.83%
Reduce
38 500.00K $12.77M 0.83%
0.83%
Hold
39 25.00K $12.60M 0.82%
0.82%
Hold
40 200.00K $12.48M 0.81%
0.81%
New
41 300.00K $12.18M 0.79%
0.79%
Reduce
42 500.00K $12.08M 0.78%
0.78%
Reduce
43 250.00K $11.90M 0.77%
0.77%
Reduce
44 300.00K $11.88M 0.77%
0.77%
New
45 200.00K $11.78M 0.76%
0.76%
Reduce
46 40.00K $11.65M 0.76%
0.76%
Hold
47 150.00K $11.47M 0.74%
0.74%
Reduce
48 25.00K $10.98M 0.71%
0.71%
Reduce
49 325.00K $10.46M 0.68%
0.68%
New
50 150.00K $10.40M 0.67%
0.67%
Add

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 40% R 40% F1 40% (modelled on 2026-Q2; 4/10 hit)

Low-confidence forecast This fund replaces about 48% of its Top-10 each quarter and backtests at F1 54% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 54% · recall 54% · F1 54% · avg rank error 3.5 · Top-10 turnover 48%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 50% 50% WBA · ABBV · THC · NVS · REGN · BSX · SNY · TFX · LLY · EHC THC · BSX · CYTK · MRK · EHC · WBA · ELV · VKTX · ABBV · UHS
2024-Q2 50% 50% 50% THC · BSX · CYTK · MRK · WBA · EHC · ELV · UHS · TARS · ABBV INSM · THC · CYTK · BSX · ELV · BPMC · NVS · LBPH · MRK · HUM
2024-Q3 70% 70% 70% INSM · THC · CYTK · BSX · ELV · BPMC · NVS · MRK · LBPH · HUM INSM · THC · BSX · CYTK · LBPH · INSP · MDT · BPMC · EHC · NVS
2024-Q4 50% 50% 50% INSM · THC · BSX · CYTK · INSP · LBPH · MDT · BPMC · EHC · NVS THC · BSX · VERA · CYTK · INSM · CNC · CAH · LLY · EHC · RVMD
2025-Q1 60% 60% 60% VERA · THC · BSX · CYTK · CNC · LLY · INSM · CAH · EHC · RVMD INSM · BSX · CYTK · THC · MLYS · ELV · NVS · VERA · EHC · MDT
2025-Q2 70% 70% 70% INSM · BSX · CYTK · MLYS · THC · VERA · ELV · MDT · NVS · EHC INSM · BSX · THC · EHC · MLYS · BTSG · VERA · DGX · REGN · NVS
2025-Q3 60% 60% 60% INSM · BSX · THC · MLYS · EHC · BTSG · REGN · DGX · VERA · RDNT THC · MLYS · VERA · CYTK · QURE · BTSG · BSX · NAMS · REGN · ALHC
2025-Q4 30% 30% 30% THC · MLYS · VERA · CYTK · BTSG · QURE · REGN · ALHC · NAMS · ALNY INSM · RVMD · VERA · REGN · MDT · ISRG · RYTM · ALHC · CAH · CVS
2026-Q1 50% 50% 50% INSM · RVMD · VERA · REGN · MDT · ISRG · RYTM · ALHC · CVS · CAH INSM · CYTK · REGN · VERA · CAH · ROIV · BTSG · RYTM · MRK · EWTX
2026-Q2 60% 60% 60% INSM · REGN · CYTK · VERA · ROIV · CAH · RYTM · MRK · RVMD · BTSG INSM · CYTK · CVS · EWTX · VERA · AXSM · CAH · ROIV · RYTM · EW
2026-Q3 ★ 40% 40% 40% INSM · CYTK · CVS · EWTX · AXSM · ROIV · VERA · CAH · EW · RYTM RVMD · INSM · CYTK · MRK · SRRK · CNC · AXSM · VERA · AMGN · LFST

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings30 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return+1.28%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+18.30%vs benchmark
Barra annualised vol26.6%Model estimate
Realised vol27.4%Annualised in window
Weighted beta0.67Raw exposure
Factor / specific risk60% / 40%Share of variance
Top-10 concentration71.8%Of reported value
Portfolio value (start = 100)78.385.492.599.6106.710-0110-2311-16Integral Health Asset Management, LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+1.28%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+18.30%Portfolio − benchmark
Arithmetic return sum+1.75%Difference vs compounded is the cross term
Weighted raw beta0.67Weighted holding betas
Realised volatility (annualised)27.44%Daily returns in window
Barra model volatility (annualised)26.64%Factor + specific
Factor share of variance59.8%Barra factors
Specific share of variance40.2%Stock residuals
Reported value$778.0M13F long US equity

2. Return attribution

The +1.75% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +2.12% 121.2%
Momentum & Growth 3 -4.60% -263.1%
Volatility & Tail Risk 7 +4.84% 276.8%
Industry 12 +6.91% 395.1%
Specific 1 -7.52% -429.9%
Return attribution (style + industry, %)-7.1-3.5+0.0+3.5+7.1Consumer Staples+0.35Short-term Reversal+0.46Non-linear Size+0.55Leverage (Downside Vol)+0.73Growth-0.76Turnover+0.81Beta-0.87Size+1.29Historical Volatility-2.89Skewness-3.13Momentum-4.30Residual Volatility+4.80Kurtosis+6.19Health Care+6.55
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.94 +6.98% +6.55% 374.5%
Kurtosis Style +0.82 +7.51% +6.19% 353.8%
Residual Volatility Style +1.46 +3.29% +4.80% 274.4%
Size Style -0.66 -1.95% +1.29% 73.8%
Turnover Style -0.17 -4.80% +0.81% 46.4%
Leverage (Downside Vol) Style -0.42 -1.71% +0.73% 41.5%
Non-linear Size Style +0.55 +1.01% +0.55% 31.6%
Short-term Reversal Style +0.53 +0.87% +0.46% 26.5%
Consumer Staples Industry +0.03 +12.82% +0.35% 20.2%
Mid Cap Style +0.13 -1.94% -0.25% -14.5%
Amihud Illiquidity Style +0.71 -0.45% -0.31% -18.0%
Growth Style -0.44 +1.75% -0.76% -43.6%
Beta Style -0.20 +4.44% -0.87% -49.6%
Historical Volatility Style +0.21 -14.00% -2.89% -165.4%
Skewness Style +0.71 -4.39% -3.13% -179.0%
Momentum Style +1.08 -4.00% -4.30% -246.0%
Specific Specific — — -7.52% -429.9%

3. Risk attribution

Annualised volatility is 26.64%; factor risk explains 59.8% of variance and specific risk 40.2%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-43.4-21.7+0.0+21.7+43.4Beta-1.73Non-linear Size-1.12Skewness-0.49Industrials+0.52Consumer Staples+0.60Amihud Illiquidity+1.32Short-term Reversal+1.52Leverage (Downside Vol)+1.81Size+3.05Kurtosis+3.47Residual Volatility+4.93Momentum+12.40Health Care+33.64Specific+40.17
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 40.2% +10.70% 10.7%
Health Care Industry +0.94 33.6% +8.96% 9.0%
Momentum Style +1.08 12.4% +3.30% 3.3%
Residual Volatility Style +1.46 4.9% +1.31% 1.3%
Kurtosis Style +0.82 3.5% +0.93% 0.9%
Size Style -0.66 3.0% +0.81% 0.8%
Leverage (Downside Vol) Style -0.42 1.8% +0.48% 0.5%
Short-term Reversal Style +0.53 1.5% +0.40% 0.4%
Amihud Illiquidity Style +0.71 1.3% +0.35% 0.3%
Consumer Staples Industry +0.03 0.6% +0.16% 0.2%
Industrials Industry +0.03 0.5% +0.14% 0.1%
Historical Volatility Style +0.21 -0.2% -0.07% -0.1%
Skewness Style +0.71 -0.5% -0.13% -0.1%
Non-linear Size Style +0.55 -1.1% -0.30% -0.3%
Beta Style -0.20 -1.7% -0.46% -0.5%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-0.9-0.10.71.52.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.66 +2.10 -2.76
Non-linear Size +0.55 +1.68 -1.13
Mid Cap +0.13 +0.13 +0.01
Beta -0.20 +1.29 -1.49
Momentum +1.08 +0.72 +0.36
Short-term Reversal +0.53 -0.64 +1.17
Residual Volatility +1.46 -0.40 +1.86
Historical Volatility +0.21 +0.86 -0.65
Liquidity +0.09 +0.11 -0.02
Amihud Illiquidity +0.71 +1.16 -0.45
Turnover -0.17 +0.21 -0.38
Growth -0.44 +0.58 -1.02
Leverage (Downside Vol) -0.42 +0.14 -0.57
Skewness +0.71 +0.24 +0.47
Kurtosis +0.82 +0.21 +0.61
Max Drawdown -0.01 -0.08 +0.07

5. Industry allocation & Brinson

Industry allocation (weight, %)-9.418.846.975.0103.2Information TechnologyCommunication ServicesUtilitiesConsumer DiscretionaryConsumer StaplesIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Health Care 93.8% 1.7% +1.23% +8.29% +23.40% -0.12% -6.50% +1.01%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Consumer Staples 2.8% 0.8% +3.38% +15.26% +0.62% -0.10% -0.23% -0.03%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 3.4% 11.1% -7.09% +4.36% -1.65% -1.27% +0.88% -0.73%
Total +24.04% +14.96% -22.30% +16.70%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
RVMD REVOLUTION MEDICINES INC Health Care 16.75% -18.70% -3.13% Add
INSM INSMED INC Health Care 16.58% +7.66% +1.27% Hold
MRK MERCK & CO INC Health Care 8.40% -0.58% -0.05% Add
SRRK SCHOLAR ROCK HLDG CORP Health Care 7.80% -7.82% -0.61% Add
CNC CENTENE CORP DEL Health Care 5.99% +20.36% +1.22% Add
AMGN AMGEN INC Health Care 4.06% +9.68% +0.39% New
REGN REGENERON PHARMACEUTICALS Health Care 3.90% +25.60% +1.00% Hold
TNGX TANGO THERAPEUTICS INC Health Care 2.89% -3.13% -0.09% Hold
CVS CVS HEALTH CORP Consumer Staples 2.75% +3.38% +0.09% Reduce
VRTX VERTEX PHARMACEUTICALS INC Health Care 2.69% +2.86% +0.08% Hold
BBIO BRIDGEBIO PHARMA INC Health Care 2.54% +17.57% +0.45% Add
ONC BEONE MEDICINES LTD Health Care 2.35% +12.39% +0.29% New
ROIV ROIVANT SCIENCES LTD Health Care 2.35% +5.58% +0.13% Hold
BDX BECTON DICKINSON & CO Health Care 2.30% +20.93% +0.48% New
BSX BOSTON SCIENTIFIC CORP Health Care 2.24% +0.09% +0.00% Reduce
MDT MEDTRONIC PLC Health Care 1.94% +19.23% +0.37% Reduce
NVS NOVARTIS AG Health Care 1.83% +12.37% +0.23% Reduce
MDGL MADRIGAL PHARMACEUTICALS INC Health Care 1.62% -15.87% -0.26% Hold
BMY BRISTOL-MYERS SQUIBB CO Health Care 1.60% +1.89% +0.03% New
LIVN LIVANOVA PLC Health Care 1.47% +20.84% +0.31% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 INSM Health Care 16.58% +7.66% +1.27%
2 CNC Health Care 5.99% +20.36% +1.22%
3 REGN Health Care 3.90% +25.60% +1.00%
4 BDX Health Care 2.30% +20.93% +0.48%
5 BBIO Health Care 2.54% +17.57% +0.45%
6 AMGN Health Care 4.06% +9.68% +0.39%
7 MDT Health Care 1.94% +19.23% +0.37%
8 LIVN Health Care 1.47% +20.84% +0.31%
9 MDGL Health Care 1.62% -15.87% -0.26%
10 TXG Industrials 0.81% -39.14% -0.32%
11 ALNY Health Care 0.95% -35.26% -0.34%
12 SRRK Health Care 7.80% -7.82% -0.61%
13 RVMD Health Care 16.75% -18.70% -3.13%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +1.28%, versus -17.01% for the QQQ synthetic benchmark — an excess of +18.30%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +6.55%, Kurtosis +6.19%, Residual Volatility +4.80%; the largest drags came from Momentum -4.30%, Skewness -3.13%, Historical Volatility -2.89%. Specific (stock-level) return contributed -7.52%.
  3. Risk attribution: Barra model volatility is 26.64% annualised; factor risk explains 60% of variance and specific risk 40%. The largest factor risk sources are Health Care 33.6%, Momentum 12.4%, Residual Volatility 4.9%.
  4. Style tilt: size -0.66, momentum +1.08, volatility +0.21, liquidity +0.09; the weighted raw beta is 0.67. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+92.1 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +24.04%, selection +14.96% and interaction -22.30%.
  6. Concentration: the top-10 positions are 71.8% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Integral Health Asset Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Integral Health Asset Management, LLC reported 94 equity positions worth $1.54B in aggregate; its largest disclosed positions were RVMD ($130.34M), INSM ($128.98M), CYTK ($72.50M).

How large is Integral Health Asset Management, LLC's portfolio?

Integral Health Asset Management, LLC reported $1.54B of long equity holdings across 94 positions as of 2026-Q3. Top-10 holdings account for 41.9% of reported value.

What is Integral Health Asset Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/integral-health-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →